Q-Linea
Infection diagnostics company developing rapid AST solutions for sepsis.
QLINEA | ST
Overview
Corporate Details
- ISIN(s):
- SE0011527845 (+2 more)
- LEI:
- 549300BXVB4XRM8WSC73
- Country:
- Sweden
- Address:
- Dag Hammarskjölds väg 52A, 752 37 Uppsala
- Website:
- https://www.qlinea.com/
- Sector:
- Manufacturing
Description
Q-Linea is an infection diagnostics company that develops and manufactures solutions for infectious diseases, with a primary focus on sepsis. The company's core product is the ASTar instrument, a fully automated, benchtop system that provides rapid phenotypic antimicrobial susceptibility testing (AST) directly from positive blood cultures. The ASTar system is designed to significantly reduce the time to result compared to traditional diagnostic methods, which can take up to 48 hours. By delivering faster results, the technology enables clinicians to make earlier, more informed decisions on appropriate antibiotic treatments for critically ill patients. This capability aims to improve patient outcomes, support antibiotic stewardship, and help combat the development of antimicrobial resistance.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-31 11:43 | Swedish | 13.6 KB | |||
| 2025-03-31 10:50 |
Förändrat antal aktier och röster i Q-linea AB (publ)
|
Swedish | 51.0 KB | ||
| 2025-03-18 15:15 |
Additional allocation of units within the framework of recently completed issues
|
English | 51.2 KB | ||
| 2025-03-18 15:15 |
Ytterligare tilldelning av units inom ramen för nyligen genomförda emissioner
|
Swedish | 52.7 KB | ||
| 2025-03-18 07:30 |
Q-linea förväntar sig att accelerera ASTar®-installationer under 2025 och 2026 …
|
Swedish | 69.2 KB | ||
| 2025-03-18 07:30 |
Q-linea anticipates accelerating ASTar® placements through 2025 and 2026 drivin…
|
English | 67.8 KB | ||
| 2025-03-11 13:19 | Swedish | 9.1 KB | |||
| 2025-03-07 23:47 |
Ramavtal tecknat med ett stort amerikanskt referenslaboratorium
|
Swedish | 51.6 KB | ||
| 2025-03-07 23:47 |
Master Service Agreement signed with large US reference laboratory
|
English | 51.9 KB | ||
| 2025-03-03 14:15 |
NOTICE OF EXTRAORDINARY GENERAL MEETING IN Q-LINEA AB (PUBL)
|
English | 63.1 KB | ||
| 2025-03-03 14:15 |
KALLELSE TILL Extra Bolagsstämma I Q-linea AB (PUBL)
|
Swedish | 62.8 KB | ||
| 2025-02-28 17:37 | Swedish | 9.5 KB | |||
| 2025-02-28 08:30 |
Förändrat antal aktier och röster i Q-linea AB (publ)
|
Swedish | 51.8 KB | ||
| 2025-02-28 08:30 |
New number of shares and votes in Q-linea AB (publ)
|
English | 51.7 KB | ||
| 2025-02-28 07:30 | Swedish | 602.6 KB |
Automate Your Workflow. Get a real-time feed of all Q-Linea filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Q-Linea
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Q-Linea via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-21 | James Kathrein | Other | Other | 5,692,547 | 170,776.41 SEK |
| 2025-05-21 | Stuart Gander | Other | Other | 5,000,000 | 150,000.00 SEK |
| 2025-05-19 | Erika Kjellberg Eriksson | Other | Other | 5,000,000 | 150,000.00 SEK |
| 2025-05-19 | Erika Kjellberg Eriksson | Other | Other | 3,234,000 | 97,020.00 SEK |
| 2023-08-03 | Nexttobe AB | Other | Buy | 23,132,612 | 69,397,836.00 SEK |
| 2023-07-21 | Christer Samuelsson | Other | Other | 30,000 | 90,000.00 SEK |
| 2023-03-14 | Christer Samuelsson | Other | Buy | 16,000 | 141,731.01 SEK |
| 2023-03-13 | Christer Samuelsson | Other | Buy | 4,000 | 41,398.00 SEK |
| 2023-02-28 | Jonas Jarvius | Other | Buy | 41,646 | 437,283.00 SEK |
| 2023-02-28 | CFO Akuten AB | Other | Buy | 10,761 | 112,955.62 SEK |
Peer Companies
